NRG GY020

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Endometrial, Gynecologic

Status:

Open

A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer

Eligible for screening study DCP 001

NCT#04214067